Loading company
Repligen Corp.
RGEN · Nasdaq · ·
Next earnings: October 27, 2026
$194.62+0.3%Sep 29 close
- 1M
- +10.4%
- 6M
- +74.6%
- 1Y
- +45.6%
- 5Y
- -36.7%
RGEN · Nasdaq · ·
Next earnings: October 27, 2026
$194.62+0.3%Sep 29 close
Repligen Corp. is scheduled to report next on October 27, 2026. The date comes from Nasdaq’s earnings calendar, and companies sometimes move it.
The quarter ending June 30, 2026, against the same quarter a year earlier.
| Measure | 3 months toJun 30, 2026 | 3 months toJun 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $204.1M | $182.4M | +11.93% |
| Profit | $5M | $14.9M | -66.31% |
| Profit per share | $0.09 | $0.26 | -65.38% |
| Free Cash Flow | $27.4M | $21.5M | +27.54% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Releases land after the close or before the open, so the move is the session that follows.
Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. We are “inspiring advances in bioprocessing” for the customers we serve; primarily biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. Our focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Our corporate headquarters are located in Waltham, Massachusetts, and the majority of our manufacturing sites are in the U.S., with additional key sites in Estonia, Germany, Ireland, the Netherlands and Sweden.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from Repligen Corp.’s Item 2.02 8-K filed July 28, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
Repligen Corp. has no earnings call transcript available.